The following question is for the Ask Dr Barken
Call In Show on Tuesday, Jan. 17th at 6pm Pacific
Time. Dial 1-877-727-3301 to hear the program.
Question of the week:
What is the difference between hormone-insensitive,
hormone-refractory, hormone-independent and
castration-resistant prostate cancer?
Dr. Barken answers this question and introduces
a video lecture about the subject.
Charles Drake, M.D. of Johns Hopkins discusses new
drugs in the pipeline for prostate cancer. This presentation
took place at the annual Prostate Cancer Research Institute
public conference 2011.
MDV3100 for the treatment of prostate cancer.
De-Bono JS., Expert Opin Investig Drugs. 2012 Jan 10